Pfizer Inc.
PFE
$26.32
$0.3751.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 112.17% | 287.45% | -98.24% | -43.80% | -167.46% |
| Total Depreciation and Amortization | 7.32% | 12.35% | 10.14% | 17.90% | 10.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 205.97% | -106.88% | 98.82% | -43.69% | -319.78% |
| Change in Net Operating Assets | -65.37% | 173.31% | 9.73% | 39.42% | 246.03% |
| Cash from Operations | 28.26% | 94.27% | -47.43% | -10.07% | -38.94% |
| Capital Expenditure | 12.16% | 19.63% | 30.31% | 38.19% | -4.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -158.79% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.11% | -182.80% | 121.34% | -45.31% | 150.34% |
| Cash from Investing | 85.24% | -331.64% | 118.05% | -47.75% | -149.34% |
| Total Debt Issued | -90.46% | 9,922.73% | -85.08% | 509.28% | 985.91% |
| Total Debt Repaid | -3,451.46% | -213.73% | -358.60% | -1,244.61% | 105.39% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.81% | -2.85% | -2.81% | -3.00% | -3.12% |
| Other Financing Activities | 22.22% | 83.78% | 55.32% | 11.47% | -357.14% |
| Cash from Financing | -193.97% | -22.68% | -109.05% | -77.95% | 208.51% |
| Foreign Exchange rate Adjustments | -2,800.00% | 128.13% | -260.00% | -1,300.00% | 96.15% |
| Miscellaneous Cash Flow Adjustments | -- | -150.00% | 200.00% | -- | 100.00% |
| Net Change in Cash | 85.71% | -94.58% | -27.79% | -221.84% | 63.79% |
